What is GRAL stock price today?

Visit our real-time dashboard for the current GRAL stock price and live market data.

Is GRAL stock going up or down today?

GRAL stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy GRAL stock now?

The decision to buy GRAL depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is GRAL a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for GRAL based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is GRAL stock overvalued or undervalued?

Use our DCF valuation calculator to determine if GRAL is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is GRAL's P/E ratio?

P/E ratio data for GRAL will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is GRAL's market cap?

GRAL (GRAIL, LLC) has a market capitalization of $2.57 billion, making it a small-cap stock.

What is GRAL's price to book ratio?

Price-to-book ratio for GRAL is available on our dashboard along with other valuation metrics.

Does GRAL pay dividends?

GRAL does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is GRAL's dividend yield?

GRAL does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is GRAL stock a good long-term investment?

GRAL's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is GRAL's revenue growth rate?

Revenue growth data for GRAL is available on our dashboard with detailed financial statement analysis.

Profitability metrics for GRAL are available on our dashboard with complete income statement analysis.

What are the risks of investing in GRAL?

Key risks for GRAL include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does GRAL compare to its competitors?

Compare GRAL to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize GRAL's performance and positioning.

What is GRAL's stock price target for 2026?

Visit our prediction page for AI-powered price targets for GRAL with bull, base, and bear case scenarios.

What do analysts say about GRAL?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for GRAL. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is GRAL's next earnings report?

GRAL reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

GRAL - GRAIL, LLC

NYSE * Healthcare * Diagnostics & Research

$0.00

+$0.00 (+0.00%)

About GRAIL, LLC

GRAIL, LLC (GRAL) common stock

Price Chart

Loading chart...

GRAL Key Statistics

Market Cap

$2.57B

How GRAL Compares to Peers

GRAL is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
GRAL(This stock)	$2.57B	N/A	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 20, 2026 at 3:21 PM EDT

Ready to invest in GRAL?

Commission-free trading available. Affiliate links.

GRAL Lician Score

10% confidence

6.0/10

Good

GRAL has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates GRALacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

GRAL Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for GRAL

Dashboard

Enter a ticker to analyze